HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pasquale Amoia Selected Research

prolinamide

1/2019The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro.
5/2018Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pasquale Amoia Research Topics

Disease

3Glioma (Gliomas)
07/2020 - 05/2018
1Inflammation (Inflammations)
07/2020
1Neoplasms (Cancer)
07/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2019
1Obesity
07/2019
1Hypertension (High Blood Pressure)
07/2019
1Gallstones (Gallstone)
10/2018
1Cholestasis
10/2018

Drug/Important Bio-Agent (IBA)

3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2020 - 05/2018
2prolinamideIBA
01/2019 - 05/2018
1compound 17IBA
07/2020
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2020
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2019
1CM544IBA
01/2019
1acetamidineIBA
01/2019
1LipidsIBA
10/2018
1Biological ProductsIBA
05/2018

Therapy/Procedure

2Therapeutics
07/2019 - 05/2018